TSPRX
Price
$5.23
Change
+$0.13 (+2.55%)
Updated
Apr 23 closing price
Net Assets
80.9M
VEXRX
Price
$94.76
Change
+$2.20 (+2.38%)
Updated
Apr 24 closing price
Net Assets
19.79B
Ad is loading...

TSPRX vs VEXRX

Header iconTSPRX vs VEXRX Comparison
Open Charts TSPRX vs VEXRXBanner chart's image
Transamerica Small Cap Growth R
Price$5.23
Change+$0.13 (+2.55%)
VolumeN/A
Net Assets80.9M
Vanguard Explorer Adm
Price$94.76
Change+$2.20 (+2.38%)
VolumeN/A
Net Assets19.79B
TSPRX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TSPRX vs. VEXRX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TSPRX is a StrongBuy and VEXRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. TSPRX (80.9M). VEXRX pays higher dividends than TSPRX: VEXRX (0.56) vs TSPRX (0.00). TSPRX was incepted earlier than VEXRX: TSPRX (8 years) vs VEXRX (23 years). TSPRX (1.51) is less costly to investors than VEXRX (0.34). TSPRX is a more actively managed with annual turnover of: 47.00 vs. VEXRX (35.00). TSPRX has a lower initial minimum investment than VEXRX: TSPRX (0) vs VEXRX (50000). VEXRX annual gain was more profitable for investors over the last year : -12.82 vs. TSPRX (-20.81). VEXRX return over 5 years is better than : 15.80 vs. TSPRX (-7.61).
TSPRXVEXRXTSPRX / VEXRX
Total Expense Ratio1.510.34444%
Annual Report Gross Expense Ratio1.510.34444%
Fund Existence8 years23 years-
Gain YTD-13.706-14.72293%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets80.9M19.8B0%
Annual Yield % from dividends0.000.56-
Returns for 1 year-20.81-12.82162%
Returns for 3 years-19.94-9.40212%
Returns for 5 years-7.6115.80-48%
Returns for 10 yearsN/A-1.76-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XBI79.101.46
+1.88%
SPDR® S&P Biotech ETF
CHI9.780.17
+1.77%
Calamos Convertible Opportunities and Income Fund
SBIO28.020.45
+1.63%
ALPS Medical Breakthroughs ETF
BCDF28.540.12
+0.44%
Horizon Kinetics Blockchain Dev ETF
FEP41.67-0.06
-0.14%
First Trust Europe AlphaDEX® ETF